These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28253895)

  • 1. EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses' Health Studies.
    Beca F; Kensler K; Glass B; Schnitt SJ; Tamimi RM; Beck AH
    Breast Cancer Res; 2017 Mar; 19(1):21. PubMed ID: 28253895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions.
    Inari H; Suganuma N; Kawachi K; Yoshida T; Yamanaka T; Nakamura Y; Yoshihara M; Nakayama H; Yamanaka A; Masudo K; Oshima T; Yokose T; Rino Y; Shimizu S; Miyagi Y; Masuda M
    BMC Cancer; 2017 Feb; 17(1):160. PubMed ID: 28241804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Proliferative Activity of Mammary Epithelial Cells in Normal Tissue Predicts Breast Cancer Risk in Premenopausal Women.
    Huh SJ; Oh H; Peterson MA; Almendro V; Hu R; Bowden M; Lis RL; Cotter MB; Loda M; Barry WT; Polyak K; Tamimi RM
    Cancer Res; 2016 Apr; 76(7):1926-34. PubMed ID: 26941287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development.
    Kunju LP; Cookingham C; Toy KA; Chen W; Sabel MS; Kleer CG
    Mod Pathol; 2011 Jun; 24(6):786-93. PubMed ID: 21399615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer.
    Lobo J; Rodrigues Â; Antunes L; Graça I; Ramalho-Carvalho J; Vieira FQ; Martins AT; Oliveira J; Jerónimo C; Henrique R
    Urol Oncol; 2018 Apr; 36(4):161.e7-161.e17. PubMed ID: 29174711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and progesterone receptor levels in nonneoplastic breast epithelium of breast cancer cases versus benign breast biopsy controls.
    Woolcott CG; SenGupta SK; Hanna WM; Aronson KJ
    BMC Cancer; 2008 May; 8():130. PubMed ID: 18466613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features.
    Guo S; Li X; Rohr J; Wang Y; Ma S; Chen P; Wang Z
    Diagn Pathol; 2016 Apr; 11():41. PubMed ID: 27113214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2 Protein Expression in Estrogen Receptor Positive Invasive Breast Cancer Treated With Neoadjuvant Endocrine Therapy: An Exploratory Study of Association With Tumor Response.
    Gan Y; Lo Y; Makower D; Kleer C; Lu J; Fineberg S
    Appl Immunohistochem Mol Morphol; 2022 Oct; 30(9):614-622. PubMed ID: 36048167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer.
    Wu J; Crowe DL
    Oncol Rep; 2015 Jul; 34(1):455-60. PubMed ID: 25998860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.
    Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ
    Cancer; 2006 Sep; 107(6):1240-7. PubMed ID: 16902983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study.
    Posso M; Corominas JM; Serrano L; Román M; Torá-Rocamora I; Domingo L; Romero A; Quintana MJ; Vernet-Tomas M; Baré M; Vidal C; Sánchez M; Saladié F; Natal C; Ferrer J; Servitja S; Sala M; Castells X;
    Cancer Med; 2017 Jun; 6(6):1482-1489. PubMed ID: 28470951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma.
    Ho TH; Kapur P; Eckel-Passow JE; Christie A; Joseph RW; Serie DJ; Cheville JC; Thompson RH; Homayoun F; Panwar V; Brugarolas J; Parker AS
    J Clin Oncol; 2017 Nov; 35(32):3706-3713. PubMed ID: 28976794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor expression in benign breast epithelium and breast cancer risk.
    Khan SA; Rogers MA; Khurana KK; Meguid MM; Numann PJ
    J Natl Cancer Inst; 1998 Jan; 90(1):37-42. PubMed ID: 9428781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of
    Ma SJ; Liu YM; Zhang YL; Chen MW; Cao W
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29089464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer.
    Collett K; Eide GE; Arnes J; Stefansson IM; Eide J; Braaten A; Aas T; Otte AP; Akslen LA
    Clin Cancer Res; 2006 Feb; 12(4):1168-74. PubMed ID: 16489070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for breast cancer development by tumor characteristics among women with benign breast disease.
    Figueroa JD; Gierach GL; Duggan MA; Fan S; Pfeiffer RM; Wang Y; Falk RT; Loudig O; Abubakar M; Ginsberg M; Kimes TM; Richert-Boe K; Glass AG; Rohan TE
    Breast Cancer Res; 2021 Mar; 23(1):34. PubMed ID: 33736682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyploid giant cancer cells, EZH2 and Myc upregulation in mammary epithelial cells infected with high-risk human cytomegalovirus.
    Nehme Z; Pasquereau S; Haidar Ahmad S; El Baba R; Herbein G
    EBioMedicine; 2022 Jun; 80():104056. PubMed ID: 35596973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA.
    Kumari K; Das B; Adhya A; Chaudhary S; Senapati S; Mishra SK
    Cell Death Dis; 2018 Feb; 9(2):152. PubMed ID: 29396474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit Is Required for Uterine Epithelial Integrity.
    Fang X; Ni N; Lydon JP; Ivanov I; Bayless KJ; Rijnkels M; Li Q
    Am J Pathol; 2019 Jun; 189(6):1212-1225. PubMed ID: 30954472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
    De Brot M; Rocha RM; Soares FA; Gobbi H
    Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.